As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and ...

The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs ...

A new commission will investigate the prevalence of SSRI antidepressants as adverse event reports document hundreds of cases ...

The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

The US Food and Drug Administration (FDA) began daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). This represents a significant step forward in modernizing ...

Study results highlight the need to improve adverse event cost quantification in oncology cost-effectiveness analyses, researchers say.